Skip to content

Auriculotherapy in the treatment of cervical pain

Pilot study on the use of french auriculotherapy in the treatment of cervical pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-3rkv2pf
Enrollment
Unknown
Registered
2020-12-10
Start date
2020-07-22
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck pain

Interventions

Pilot study with only a group of 20 patients with cervical pain, treated by ear acupuncture, for 6 sessions, once a week (total treatment time: 6 weeks) and followed for up to 3 months after the end o
E02.190.044.133

Sponsors

Fernando Mendes Sant'Anna
Lead Sponsor

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pain in the cervical area as the main complaint. Neck disability index greater than 5. Absence of a history of surgery, fracture or severe injury in the cervical region. Absence of allergies or injuries in both ears. Consent not to receive other treatments during the study period, except analgesics, if necessary.

Exclusion criteria

Exclusion criteria: Pregnancy. Serious injuries or signs of infection in one or both ears. Serious systemic pathologies such as autoimmune diseases or cancer.

Design outcomes

Primary

MeasureTime frame
The primary endpoints of the study is to measure the intensity of pain and functional disability, using the visual analog scale (VAS) of pain and the neck disability index (NDI), one and two months after the end of treatment.We expect to be a decrease of at least 30% in pain intensity and neck disability index of these patients, and the sample size was calculated to have a 90% power with an alpha type error of 0.05 to detect such a difference.

Secondary

MeasureTime frame
The secondary objective is to compare the quality of life score using the SF-12 (12-item health survey) before treatment and 2 months after the end of treatment.

Countries

Brazil

Contacts

Public ContactFernando Sant Anna
fmsantanna@gmail.com+55 22 999030683

Outcome results

None listed

Source: REBEC (via WHO ICTRP)